Literature DB >> 10954568

Localization of human immunodeficiency virus type 1 Gag and Env at the plasma membrane by confocal imaging.

L Hermida-Matsumoto1, M D Resh.   

Abstract

Budding of lentiviruses occurs at the plasma membrane, but the preceding steps involved in particle assembly are poorly understood. Since the Gag polyprotein mediates virion assembly and budding, studies on the localization of Gag within the cell should provide insight into the mechanism of particle assembly. Here, we utilize biochemical fractionation techniques as well as high-resolution confocal imaging of live cells to demonstrate that Gag is localized at the plasma membrane in a striking punctate pattern. Mutation of the N-terminal myristoylation site results in the formation of large cytosolic complexes, whereas mutation of the N-terminal basic residue cluster in the matrix domain redirects the Gag protein to a region partially overlapping the Golgi apparatus. In addition, we show that Gag and Env colocalize at the plasma membrane and that mistargeting of a mutant Gag to the Golgi apparatus alters the pattern of surface expression of Env.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10954568      PMCID: PMC116378          DOI: 10.1128/jvi.74.18.8670-8679.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

Review 1.  Cellular functions regulated by Src family kinases.

Authors:  S M Thomas; J S Brugge
Journal:  Annu Rev Cell Dev Biol       Date:  1997       Impact factor: 13.827

2.  Comparison of the NMR and X-ray structures of the HIV-1 matrix protein: evidence for conformational changes during viral assembly.

Authors:  M A Massiah; D Worthylake; A M Christensen; W I Sundquist; C P Hill; M F Summers
Journal:  Protein Sci       Date:  1996-12       Impact factor: 6.725

3.  Electrostatics and the membrane association of Src: theory and experiment.

Authors:  D Murray; L Hermida-Matsumoto; C A Buser; J Tsang; C T Sigal; N Ben-Tal; B Honig; M D Resh; S McLaughlin
Journal:  Biochemistry       Date:  1998-02-24       Impact factor: 3.162

4.  Membrane-induced alterations in HIV-1 Gag and matrix protein-protein interactions.

Authors:  S Scarlata; L S Ehrlich; C A Carter
Journal:  J Mol Biol       Date:  1998-03-27       Impact factor: 5.469

5.  Direct interaction between the envelope and matrix proteins of HIV-1.

Authors:  P Cosson
Journal:  EMBO J       Date:  1996-11-01       Impact factor: 11.598

6.  Membrane binding of human immunodeficiency virus type 1 matrix protein in vivo supports a conformational myristyl switch mechanism.

Authors:  P Spearman; R Horton; L Ratner; I Kuli-Zade
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

7.  p80/85 cortactin associates with the Src SH2 domain and colocalizes with v-Src in transformed cells.

Authors:  H Okamura; M D Resh
Journal:  J Biol Chem       Date:  1995-11-03       Impact factor: 5.157

8.  Cryo-electron microscopy reveals ordered domains in the immature HIV-1 particle.

Authors:  S D Fuller; T Wilk; B E Gowen; H G Kräusslich; V M Vogt
Journal:  Curr Biol       Date:  1997-10-01       Impact factor: 10.834

9.  Rescue of human immunodeficiency virus type 1 matrix protein mutants by envelope glycoproteins with short cytoplasmic domains.

Authors:  F Mammano; E Kondo; J Sodroski; A Bukovsky; H G Göttlinger
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

10.  The I domain is required for efficient plasma membrane binding of human immunodeficiency virus type 1 Pr55Gag.

Authors:  S Sandefur; V Varthakavi; P Spearman
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

View more
  152 in total

1.  Palmitoylation of the HIV-1 envelope glycoprotein is critical for viral infectivity.

Authors:  I Rousso; M B Mixon; B K Chen; P S Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

2.  Plasma membrane rafts play a critical role in HIV-1 assembly and release.

Authors:  A Ono; E O Freed
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

3.  Role of RNA in facilitating Gag/Gag-Pol interaction.

Authors:  Ahmad Khorchid; Rabih Halwani; Mark A Wainberg; Lawrence Kleiman
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

Review 4.  Genetic subtypes, humoral immunity, and human immunodeficiency virus type 1 vaccine development.

Authors:  J P Moore; P W Parren; D R Burton
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

5.  The late stage of human immunodeficiency virus type 1 assembly is an energy-dependent process.

Authors:  M Tritel; M D Resh
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

6.  Rapid localization of Gag/GagPol complexes to detergent-resistant membrane during the assembly of human immunodeficiency virus type 1.

Authors:  Rabih Halwani; Ahmad Khorchid; Shan Cen; Lawrence Kleiman
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

7.  Intracellular trafficking of Gag and Env proteins and their interactions modulate pseudotyping of retroviruses.

Authors:  Virginie Sandrin; Delphine Muriaux; Jean-Luc Darlix; François-Loïc Cosset
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

8.  NC-mediated nucleolar localization of retroviral gag proteins.

Authors:  Timothy L Lochmann; Darrin V Bann; Eileen P Ryan; Andrea R Beyer; Annie Mao; Alan Cochrane; Leslie J Parent
Journal:  Virus Res       Date:  2012-10-02       Impact factor: 3.303

9.  Alterations in the MA and NC domains modulate phosphoinositide-dependent plasma membrane localization of the Rous sarcoma virus Gag protein.

Authors:  Shorena Nadaraia-Hoke; Darrin V Bann; Timothy L Lochmann; Nicole Gudleski-O'Regan; Leslie J Parent
Journal:  J Virol       Date:  2013-01-16       Impact factor: 5.103

10.  Direct measurement of Gag-Gag interaction during retrovirus assembly with FRET and fluorescence correlation spectroscopy.

Authors:  Daniel R Larson; Yu May Ma; Volker M Vogt; Watt W Webb
Journal:  J Cell Biol       Date:  2003-09-29       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.